Tiger Legatus Capital Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
6CM
TCM
AA
Tiger Legatus Capital Management's CDLX Position: Q2 2020 in Review
Tiger Legatus Capital Management sold out of Cardlytics (CDLX) in Q2 2020, closing a stake of 6,500 shares — an estimated $2.27M sold.
Tiger Legatus Capital Management first reported a position in CDLX in Q1 2020 and held it in 1 quarter. The position peaked at $2.27M in Q1 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q2 2020.
- Tiger Legatus Capital Management reported no remaining Cardlytics position as of Q2 2020 after selling out during the quarter.
- Tiger Legatus Capital Management sold 6,500 Cardlytics shares in Q2 2020, an estimated $2.27M.
- Tiger Legatus Capital Management first reported a position in Cardlytics in Q1 2020 and held it in 1 quarter.
- Tiger Legatus Capital Management's Cardlytics position peaked at $2.27M in Q1 2020.
- 164 funds tracked by Wall St. Rank held Cardlytics as of Q2 2020.
Based on Tiger Legatus Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.